MOMA-341
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MOMA-341, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]